Yokota, Mutsumi
Kakuta, Soichiro
Shiga, Takahiro
Ishikawa, Kei-ichi
Okano, Hideyuki
Hattori, Nobutaka
Akamatsu, Wado
Koike, Masato
Funding for this research was provided by:
Japan Society for the Promotion of Science (18K15466, 17K08522, 20K07743)
Ministry of Education, Culture, Sports, Science and Technology (S1411007, S1411007, S1411007)
Japan Agency for Medical Research and Development (JP19ek0109244, JP19ek0109244, JP19ek0109244, JP17bm0804003, JP17bm0804003, JP20bm0804003)
Juntendo University
Article History
Received: 4 September 2020
Accepted: 15 March 2021
First Online: 23 March 2021
Ethics approval and consent to participate
: The genetic analysis in the current study was performed under the guidelines of the recombinant DNA experiments committee of Juntendo University (Approval Number 27-3). The use of human iPSCs was approved by the Ethical Committees of Juntendo University School of Medicine (Approval Number 2017032).
: Not applicable.
: Hideyuki Okano is a founding scientist and a paid scientific advisor of SanbBio Co. Ltd. and K Pharma. Co. Ltd. The other authors declare neither financial nor non-financial competing interests.